Peer Review History
| Original SubmissionAugust 25, 2025 |
|---|
|
Dear Dr. Manning, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 04 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .. We look forward to receiving your revised manuscript. Kind regards, Rong Yan Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: This work was supported by Seed Funding from the Faculty of Education and Health Sciences, University of Limerick, awarded to Dr Molly Manning in 2021. Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. We noted in your submission details that a portion of your manuscript may have been presented or published elsewhere. Please clarify whether this publication was peer-reviewed and formally published. If this work was previously peer-reviewed and published, in the cover letter please provide the reason that this work does not constitute dual publication and should be included in the current manuscript. 4. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. Additional Editor Comments: 1. Significance of the Research This manuscript addresses a critical and understudied gap in clinical practice: the absence of coordinated, context-specific psychological care for individuals with aphasia within the Irish healthcare system. The well-documented association between aphasia and adverse psychosocial outcomes, including depression, anxiety, and social isolation, underscores the urgency of this issue. The study's commitment to stakeholder co-design—centering the perspectives of people with aphasia (PWA) and interdisciplinary clinicians—aligns directly with PLOS ONE's mission to publish applied health research with tangible real-world impact. The relevance of this work is further enhanced by its grounding in the distinctive Irish healthcare context, with explicit reference to pertinent national policies such as the National Stroke Strategy 2022–27 and the Sláintecare reform program. By systematically linking local service deficiencies (e.g., constrained access to psychological services, inconsistent mood screening protocols) to broader implementation science challenges, the study occupies a unique niche in the extant literature, which frequently focuses on larger healthcare systems while neglecting smaller, contextually specific environments like Ireland. Notwithstanding these strengths, the manuscript would benefit from a more explicit articulation of the transferability of its findings beyond the local context. For instance, the identified principles of a "unified vision" and "flexible referral pathways" may yield valuable lessons for other jurisdictions grappling with comparable resource limitations or decentralized service delivery models. Elaborating on this dimension would significantly bolster the manuscript's appeal to PLOS ONE's international readership and reinforce its broader scholarly significance. The manuscript's principal innovative contribution lies in its methodological approach: the deliberate integration of Participatory Learning and Action (PLA) tools with Normalization Process Theory (NPT) to structure stakeholder engagement. While both PLA and NPT have been employed independently within aphasia research, their synergistic combination here is both deliberate and purposeful. PLA facilitates inclusive knowledge co-creation with PWA, a population often facing significant barriers to research participation, while NPT supplies a robust theoretical framework to translate these insights into implementable strategies. This dual methodology effectively addresses a recognized limitation in prior participatory studies, which often lack explicit connections to implementation science theory. The proposition of a "level 0" within the stepped care model—formally acknowledging the informal, non-clinical support systems upon which PWA frequently rely (e.g., peer networks, self-management strategies)—constitutes another substantive contribution. Although the Personal Recovery paradigm has previously informed aphasia care, the manuscript's focus on operationalizing "level 0" as an integral component of stepped care, rather than a peripheral consideration, represents a novel advancement. This approach validates the agency of PWA and recognizes that recovery processes often originate outside formal clinical settings—a conceptual shift with potential to reconfigure stepped care design for neurogenic disorders beyond aphasia. To fully realize this innovative potential, the manuscript should elaborate on the functional interplay between "level 0" and established care levels. Specifically, it should address operational considerations such as: What mechanisms would trigger referrals from level 0 to level 1? How would engagement or outcomes at level 0 be assessed in clinical practice? Providing concrete examples or stakeholder-derived operational guidelines would substantially enhance the credibility of "level 0" as an actionable clinical concept. 2. Research Methods The methodological framework is generally robust and adheres to PLOS ONE's standards for qualitative inquiry, evidenced by compliance with the Standards for Reporting Qualitative Research (SRQR) and clear documentation of ethical approval (University of Limerick, 2021_12_19). The decision to conduct separate workshops for clinicians and PWA, followed by structured cross-group knowledge integration, is particularly commendable. This approach enables candid discourse within each stakeholder group while ensuring the systematic incorporation of diverse perspectives—a crucial safeguard against tokenistic patient and public involvement. However, three significant limitations require remediation to satisfy PLOS ONE's rigor requirements: Sample Size and Diversity The participant cohort (6 clinicians, 3 PWA), while permitting in-depth participatory dialogue, exhibits limited diversity across critical dimensions. The clinician sample overrepresents senior, specialized roles (e.g., Senior Speech and Language Therapists, Clinical Neuropsychologists) while underrepresenting frontline primary care providers (e.g., General Practitioners, community nurses) who frequently function as gatekeepers to aphasia psychological care. Regarding PWA participants, all were working-aged individuals with long-term aphasia (10–15 years post-stroke), thereby excluding those with acute presentation or non-stroke etiologies (e.g., traumatic brain injury)—populations with distinct psychological needs. The authors should explicitly acknowledge these limitations and, where feasible, supplement the discussion with insights from relevant literature concerning underrepresented groups to better contextualize their findings. Transparency in Data Analysis Although the manuscript describes the employment of PLA techniques (e.g., sticky note brainstorming, card-sorting) and NPT operationalization, it lacks sufficient detail regarding systematic analytical procedures. Critical methodological information is absent, including: The specific coding methodology applied to qualitative data (e.g., inductive versus deductive approaches); Measures implemented to ensure coding reliability (e.g., independent coding by multiple researchers, consensus-building procedures); The precise application of NPT constructs to interpret emergent themes. The inclusion of a supplementary table or detailed paragraph elucidating the analytical workflow would satisfy PLOS ONE's requirement for reproducible qualitative methodologies. Data Availability The current data availability statement ("No - some restrictions will apply") fails to comply with PLOS ONE's policy mandate that authors "make all data underlying the findings described fully available, without restriction" (except where legally or ethically justified). The authors must provide explicit clarification regarding: The specific categories of data subject to restrictions (e.g., raw verbatim comments to protect participant anonymity); Accessibility procedures for non-restricted data (e.g., de-identified thematic summaries, workshop protocols); The ethical or legal rationale underpinning any restrictions (e.g., specific informed consent agreements with PWA). A comprehensive and policy-compliant data availability statement is mandatory for resubmission. 3. Writing and Presentation The manuscript demonstrates sound organizational structure and accessibility, with a coherent progression from background through methods, results, and discussion. Notable strengths include: clear explication of technical terminology (e.g., "stepped care," "PLA") appropriate for interdisciplinary readership; strategic incorporation of direct quotations from PWA, anchoring findings in lived experience; consistent alignment between stated research objectives and presented results. Nevertheless, several revisions would enhance clarity and professional presentation: Redundancy Several key points (e.g., the necessity for enhanced clinician training, barriers to interdisciplinary collaboration) are repetitively addressed across the introduction, results, and discussion sections. Maybe the authors could further streamline the similar expressions to improve readability. Table Design Tables 1 (Operationalisation of NPT Constructs) and 2 (Sequence and Focus of Meetings) require enhanced detail to ensure methodological reproducibility: Table 1 should incorporate concrete illustrations of how NPT constructs guided discussions (e.g., "Context: Prompted clinicians to examine how HSE funding constraints impact APC delivery"); Table 2 should rectify formatting inconsistencies (e.g., truncated prompts) and incorporate temporal markers (e.g., "April 2022: Clinicians 1 workshop") to clarify the research timeline. Reference Consistency The reference list contains several technical inaccuracies: Baker (20) (cited in Section 1.46) is omitted from the references; Citations for Leamy et al. (2011) and Manning et al. (2019) appear in incorrect sequence. Rectifying these errors is necessary to ensure compliance with PLOS ONE's bibliographic standards. 4. Conclusion This manuscript constitutes a valuable contribution to aphasia care research through its principled centering of stakeholder perspectives and its systematic linkage of participatory insights with actionable implementation strategies. Its focused examination of the Irish healthcare context addresses a significant literature gap, while its methodological integration of PLA and NPT offers a replicable framework for future co-design studies. Provided the authors address the identified concerns regarding sample diversity, analytical transparency, and presentational clarity, the revised manuscript will fully satisfy PLOS ONE's academic standards and serve as an important resource for clinicians, policymakers, and researchers dedicated to enhancing psychological support for people with aphasia. To facilitate efficient re-evaluation, the authors should prioritize the following revisions: 1) Elaborate the discussion regarding the adaptability of findings to other healthcare contexts to enhance international relevance. 2) Provide concrete operational specifications for the "level 0" stepped care model, including potential referral triggers and assessment approaches. 3) Incorporate a comprehensive description of the data analysis workflow, detailing coding methodologies and reliability measures. 4) Revise the data availability statement to achieve full compliance with PLOS ONE policies, explicitly clarifying restrictions and access procedures. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
Dear Dr. Manning, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 23 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .. Kind regards, Rong Yan Academic Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: In light of the comments and feedback provided by the two reviewers, I find that your revisions have been carried out satisfactorily, and I am pleased to recommend this manuscript for publication. Prior to submitting the final version, you still need to further revise the paper in accordance with the remaining suggestions on method and discussion sections from the two reviewers. Congratulations on your work, and thank you for your valuable contribution. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Reviewer #2: Thank you for your comprehensive revisions, which have addressed the previous concerns effectively. Your manuscript is now much stronger. I have only a few minor, optional suggestions for fine-tuning the text before final publication. Thank you for your comprehensive revisions, which have addressed the previous concerns effectively. Your manuscript is now much stronger. I have only a few minor, optional suggestions for fine-tuning the text before final publication. In the “Knowledge generation and synthesis” subsection, it might be helpful to add a brief sentence explaining how the iterative thematic analysis complemented the NPT-guided discussion prompts. This would further clarify your analytical strategy for readers. Regarding the discussion on creative therapies, the evidence is currently described as “equivocal.” To maintain a strong yet perfectly balanced recommendation, you might consider phrasing that acknowledges the developing evidence base while underscoring the stakeholder-endorsed rationale for its inclusion. These are minor points aimed at final polishing. Congratulations on a well-executed and insightful study. I believe it will be of interest to the journal’s readership. Reviewer #3: This manuscript addresses an important and underdeveloped area: the participatory development and implementation planning of psychological care for people with aphasia in Ireland. The integration of Participatory Learning and Action (PLA) methods with Normalisation Process Theory (NPT) provides a coherent and contextually grounded framework. The authors have responded carefully to prior reviewer comments, and the manuscript has improved substantially in clarity, structure, and transparency. I just have some minor points concerning the Section of Materials and methods. This manuscript addresses an important and underdeveloped area: the participatory development and implementation planning of psychological care for people with aphasia in Ireland. The integration of Participatory Learning and Action (PLA) methods with Normalisation Process Theory (NPT) provides a coherent and contextually grounded framework. The authors have responded carefully to prior reviewer comments, and the manuscript has improved substantially in clarity, structure, and transparency. I just have some minor points concerning the Section of Materials and methods. 1) In the Methods section, the authors have expanded the description of the analytic process. This revision is helpful. However, it is still not fully clear whether the thematic analysis was primarily inductive, deductive (guided by NPT), or hybrid. Please specify this explicitly. 2) In the same section, the manuscript states that the first author led the coding process with ongoing scrutiny from co-authors. It would strengthen methodological transparency to clarify whether any independent coding of raw data was conducted by more than one researcher before consensus discussions took place. 3) Also in the Methods section, the manuscript notes that PPI meeting data were not formally analysed thematically but were grouped at a meta-level. Please provide a clearer methodological justification for this difference in analytic treatment and explain how this approach ensured that PPI contributions were given equal analytic weight. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy .--> Reviewer #2: Yes: Huichao Bi, School of Education, Tsinghua UniversityHuichao Bi, School of Education, Tsinghua University Reviewer #3: Yes: Baoshan ZhangBaoshan Zhang ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Advancing aphasia psychological care in Ireland: A Participatory Study with people with aphasia and clinicians PONE-D-25-43919R2 Dear Dr. Manning, Thank you for your careful attention to all the suggestions made during the review process. We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Antony Bayer Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #3: Yes ********** Reviewer #3: The authors have responded carefully to my comments and made appropriate revisions to the manuscript. I appreciate the efforts made to improve the paper. I have no additional comments and recommend acceptance of the manuscript. ********** what does this mean? ). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy .--> Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-25-43919R2 PLOS One Dear Dr. Manning, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Antony Bayer Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .